Treatment of progressing stroke.
D000925:Anticoagulants / Q000627:therapeutic use; D001929:Brain Edema / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000097:blood / Q000628:therapy*; D003911:Dextrans / Q000627:therapeutic use; D004617:Embolism / Q000628:therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005990:Glycerol / Q000627:therapeutic use; D010808:Physical Examination; D010974:Platelet Aggregation / Q000187:drug effects; D011379:Prognosis; D012214:Rheumatic Heart Disease / Q000628:therapy; D013256:Steroids / Q000627:therapeutic use
D000925:Anticoagulants; D003911:Dextrans; D005343:Fibrinolytic Agents; D013256:Steroids; D005990:Glycerol